Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Infinity Pharmaceuticals Inc (INFI)  
$0.00 0.00 (0.00%) as of 4:30 Fri 3/22


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 64,210,000
Market Cap: N/A
Last Volume: 2,748 Avg Vol: 1,546,173
52 Week Range: $0.000001 - $0.238
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Infinity Pharmaceuticals is a clinical-stage biopharmaceutical company. Co. is focused on advancing eganelisib (IPI-549), an orally administered, clinical-stage, immuno-oncology product candidate that reprograms macrophages through selective inhibition of the enzyme phosphoinositide-3-kinase-gamma. The preclinical findings indicate that eganelisib may have the potential to treat various solid tumors and represents an additive or synergistic approach to restoring anti-tumor immunity in combination with other immunotherapies such as checkpoint inhibitors. Further, preclinical studies showed that eganelisib inhibits the regrowth of tumors that can occur following treatment with chemotherapy.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 410,196 425,190
Total Sell Value $0 $0 $28,714 $38,646
Total People Sold 0 0 1 2
Total Sell Transactions 0 0 1 2
End Date 2023-12-28 2023-09-26 2023-03-28 2022-03-28

   
Records found: 227
  Page 1 of 10  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Perkins Adelene Q Director   –       •      –    2023-09-12 4 AS $0.07 $28,714 D/D (410,196) 1,175,291 -100%     
   Perkins Adelene Q Director   –       •      –    2023-09-09 4 OE $0.00 $0 D/D 768,133 1,585,487     -
   Peluso Stephane Chief Scientific Officer   •       •      –    2022-08-02 4 S $0.66 $9,932 D/D (14,994) 37,052 23%     
   Peluso Stephane Chief Scientific Officer   •       •      –    2022-08-02 4 OE $0.00 $0 D/D 50,000 52,046     -
   Evnin Anthony B   •       •      –    2022-06-16 4 A $0.68 $31,491 D/D 46,378 215,403     -
   Schwartz Brian   •       •      –    2022-06-16 4 A $0.68 $20,994 D/D 30,919 30,919     -
   Peluso Stephane Chief Scientific Officer   •       –      –    2021-08-02 3 IO $0.00 $0 D/D 0 2,046 -21%     
   Evnin Anthony B   •       •      –    2021-06-10 4 A $3.43 $10,499 D/D 3,061 169,025     -
   Beier David W   •       •      –    2021-06-10 4 A $3.43 $10,499 D/D 3,061 8,775     -
   Selby Norman C   •       •      –    2021-05-14 4 OE $0.92 $4,600 D/D 5,000 15,000     -
   Lampert Mark N 10% Owner   –       –       •   2021-02-11 4 S $5.37 $12,133,492 D/D (2,260,085) 534,847 30%     
   Lampert Mark N 10% Owner   –       –       •   2021-01-22 4 S $4.14 $24,205,855 D/D (5,848,520) 686,974 22%     
   Evnin Anthony B Director   –       •      –    2020-06-17 4 A $0.00 $0 D/D 22,826 165,964     -
   Kutok Jeffery Chief Scientific Officer   •       –      –    2020-01-10 4 A $0.00 $0 D/D 64,219 77,376     -
   Bloch Lawrence E President   •       –      –    2020-01-10 4 A $0.00 $0 D/D 83,157 745,094     -
   Perkins Adelene Q Chief Executive Officer   •       –      –    2020-01-10 4 A $0.00 $0 D/D 155,134 793,190     -
   Tasker Seth A Chief Business Officer   •       –      –    2020-01-10 4 A $0.00 $0 D/D 53,538 101,364     -
   Agresta Samuel Director   –       •      –    2019-10-16 3 IO $0.00 $0 D/D 0 10,593     -
   Evnin Anthony B Director   –       •      –    2019-06-13 4 A $1.60 $21,000 D/D 13,125 143,138     -
   Berkowitz Jeffrey Director   –       •      –    2019-06-13 4 A $1.60 $42,000 D/D 26,250 85,238     -
   Lampert Mark N 10% Owner   –       –       •   2018-12-13 4 B $1.20 $209,913 D/D 175,000 6,631,136 2.45     -
   Lampert Mark N 10% Owner   –       –       •   2018-11-28 4 B $1.30 $130,000 D/D 100,000 6,510,597 2.45     -
   Lampert Mark N 10% Owner   –       –       •   2018-11-21 4 B $1.35 $6,345 D/D 4,700 1,254,993 2.37     -
   Lampert Mark N 10% Owner   –       –       •   2018-11-19 4 B $1.35 $2,005,076 D/D 1,465,126 1,254,412 2.45     -
   Lampert Mark N 10% Owner   –       –       •   2018-11-15 4 B $1.35 $123,490 D/D 91,474 5,815,887 2.45     -

  227 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 10
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed